Work

A first-in-human trial of intravesical BH011, a novel docetaxel formulation, in patients with high risk non-muscle invasive bladder cancer (HR-NMIBC) after BCG failure: Results from a phase 1 study.

Year: 2025

Type: article

Study design: Clinical Trial

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.16_suppl.e16605

Authors: Xiaolin Lu, Dingwei Ye, Hailong Hu, Mingde Lei, Zihan Xue, Ning Kang, Qun Sun, Xiaohua Wei

Institutions: Shanghai Medical College of Fudan University, Fudan University, Fudan University Shanghai Cancer Center, Second Hospital of Tianjin Medical University, Tianjin Medical University

Language: English

Topic: Bladder and Urothelial Cancer Treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4410818449

FWCI:

Cites:

Cited by:

Related to: 10